TINY CARGO COMPANY, THE

Biotech · Private

XoLacta, a therapeutic comprised of milk extracellular vesicles loaded with drug payload to promote regenerative healing in irradiated tissues

Grants
$1.4M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel Drug Delivery Platform as Medical Countermeasure for treatment of Gastrointestinal Radiation Damage$400,000
Federal grantDepartment of Health and Human Services · Phase II · XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment$1,022,907
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3092Technology Holding, LLC——
3093MADELEINE PHARMACEUTICALS, INC.——
3094AGYPHARMA, LLC——
3095TINY CARGO COMPANY, THE——
3096NEUROLUX, INC.——
3097NEW YORK/R&D/CTR/TRANSLATIONAL MED/THER——
3098ImmPORT Therapeutics Inc dba Antigen Discovery Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.